PEDIATRICS Vol. 8 No. 4 October 1951, pp. 482-488
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GARRARD, S. D.
Right arrow Articles by HIRSCH, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GARRARD, S. D.
Right arrow Articles by HIRSCH, M. M.

PSEUDOMONAS AERUGINOSA INFECTION AS A COMPLICATION OF THERAPY IN PANCREATIC FIBROSIS (MUCOVISCIDOSIS)

STERLING D. GARRARD M.D.1, JULIUS B. RICHMOND M.D.1, and MARVIN M. HIRSCH M.D.1

1 The Department of Pediatrics, University of Illinois College of Medicine, Chicago.

Four cases of proved pancreatic fibrosis in which Ps. aeruginosa was the organism associated with the terminal, bronchopulmonary manifestations have been presented. These children had received prolonged antibacterial therapy varying from one to five years.

Ps. aeruginosa, or similarly resistant organisms, which ordinarily have a low pathogenicity, may become predominant and invasive as a result of prolonged antibacterial therapy. The opportunity for the emergence of resistant strains would seem to be enhanced by recent recommendations advocating continuous antibacterial therapy with a single compound. Intermittent therapy, alternating the various antibacterial agents and correlating their use with careful bacteriologic studies of the nasopharyngeal and tracheobronchial flora, would seem to be the logical approach to treatment in the light of present knowledge of the development of bacterial resistance. Mixtures of two antibiotics having a different mechanism of action may be more desirable than the use of a single agent.

Submitted on April 30, 1951